コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 dian 4 endoscopies (interquartile range, 3-6 endoscopies).
2 esophageal cancer within 5 years after index endoscopy.
3 ed blood lipid concentrations at the time of endoscopy.
4 are diagnosed within 1 year after the index endoscopy.
5 nsecutive patients undergoing upper GI tract endoscopy.
6 by the American Society for Gastrointestinal Endoscopy.
7 zed qualitative information such as flexible endoscopy.
8 ryology, European Society for Gynaecological Endoscopy.
9 used to triage patients requiring screening endoscopy.
10 ted Thai version of GerdQ and then underwent endoscopy.
11 to acute duodenitis following diagnostic UGI endoscopy.
12 a high miss-rate during standard white-light endoscopy.
13 and Depression scale were fulfilled prior to endoscopy.
14 llowing an uneventful upper gastrointestinal endoscopy.
15 % for (99m)Tc-CXCL8 scan and 71% and 70% for endoscopy.
16 nteers as a control group were recruited for endoscopy.
17 elopment and inflammation were determined by endoscopy.
18 n and is easily detected by nasal fiberoptic endoscopy.
19 icosteroid resistance was evaluated by nasal endoscopy.
20 gating the risk of infection associated with endoscopy.
21 ontrols) were evaluated with the FLIP during endoscopy.
22 647 BE cases swallowed a Cytosponge prior to endoscopy.
23 d high Rutgeerts score (>2) in postoperative endoscopy.
24 ient's likelihood of completing surveillance endoscopy.
25 leading to gastric eosinophilia assessed by endoscopy.
26 illation underwent postprocedural esophageal endoscopy.
27 roid resistance was evaluated by using nasal endoscopy.
28 nd The American Society for Gastrointestinal Endoscopy.
29 and histologic findings at the time of index endoscopy.
30 ulcer that had healed by the time of 3-month endoscopy.
31 he Cytosponge test before their surveillance endoscopy.
32 women with endoscopy occurred <2 weeks after endoscopy.
33 ugh, abdominal computed tomography (CT), and endoscopy.
34 nt advances in the field of gastrointestinal endoscopy.
35 were reintroduced individually, followed by endoscopy.
36 the use of small-bowel CE and colon capsule endoscopy.
37 le failed attempts at upper gastrointestinal endoscopy.
38 28 participants were randomly assigned after endoscopy.
39 pregnancies exposed to endoscopy (2025 upper endoscopies, 1109 lower endoscopies, and 58 endoscopic r
40 We identified 3052 pregnancies exposed to endoscopy (2025 upper endoscopies, 1109 lower endoscopie
41 I criteria would potentially spare 367 (40%) endoscopies (21% with Baveno VI criteria) with a risk of
43 = 0.418) and treatment failure (TIPS 38% vs. endoscopy 34%; P = 0.685) did not differ between groups.
44 enocarcinoma] underwent nCRT with CT-PET and endoscopy 4 to 6 weeks later, and surgery subsequently.
47 ee clinical remission, a Mayo Score </= 1 on endoscopy, a FC </= 200 mug/g and no significant active
48 king relying on CT alone or on a combined CT-endoscopy algorithm was similar and would have spared 19
51 copic therapy, it is appropriate to consider endoscopy among efforts to develop health system capacit
52 ent EACs (of all EACs detected after initial endoscopy) among BE cohorts, using a random effects mode
53 ity spent two or more days a week performing endoscopies and had practices comprising less than 25% o
54 ut an increase in complications or number of endoscopies and without a reduction in rebleeding or oth
55 %) among those who had not undergone a lower endoscopy and 18 colorectal cancers per 100000 person-ye
57 BE with low-grade dysplasia) at their index endoscopy and at least a 3-year follow-up period, 25% of
58 e development of diagnostic tools that avoid endoscopy and biopsy analyses to more easily monitor dis
60 ing at centers equipped with high-definition endoscopy and capable of performing endoscopic resection
61 ubjective variables, such as bleeding during endoscopy and Child-Pugh score, which are evaluated inco
67 our country, where there are restrictions to endoscopy and high prevalence of Helicobacter pylori (H.
71 or fecal calprotectin for IBD, confirmed by endoscopy and histopathology or clinical follow-up, in p
75 Secondary endpoints comprised pH testing and endoscopy and other symptoms measured by the GSRS, dysph
76 t study using routine lower gastrointestinal endoscopy and pathology data from patients who, after ba
77 osite indices, response definitions based on endoscopy and patient-reported outcomes can be readily a
78 s were adjudicated free of active disease on endoscopy and radiology at final assessment (difference,
80 the foundation for development of molecular endoscopy and summarise key results from preclinical and
81 ith continued symptoms can be evaluated with endoscopy and tests of esophageal physiology, to better
82 g course providing false negative results of endoscopy and ultrasound if performed between episodes o
84 of the vocal folds with fiber-optic or rigid endoscopy and using stroboscopic or high-speed video to
85 ndoscopy (2025 upper endoscopies, 1109 lower endoscopies, and 58 endoscopic retrograde cholangiopancr
88 omplete symptom, upper gastrointestinal (GI) endoscopy, and histology data from 1452 consecutive adul
91 sy cohorts, the screening period included an endoscopy, and participants with duodenal histology who
92 ices that are placed or removed via flexible endoscopy, and procedures that utilize instruments that
93 Journal of the American College of Surgeons, Endoscopy, Archives of Surgery, and Liver transplantatio
96 of the American Society for Gastrointestinal Endoscopy (ASGE) risk stratification guidelines versus m
98 (mean age, 50.3 y; 62% female) who underwent endoscopy at a tertiary medical center in the United Kin
101 promising target for molecular fluorescence endoscopy because it showed a high protein expression, e
102 of 23 months, 10 (29%) of 35 patients in the endoscopy + beta-blocker group, as compared to 0 of 37 (
103 3.5 years and the oesophagus was assessed by endoscopy, biopsy, endoscopic ultrasonography, and high-
104 including examination and a nasal fiberoptic endoscopy by an otorhinolaryngologist in the acute phase
107 ients attending the outpatient clinic, nasal endoscopy changed classification in only four patients (
108 sensitivities and cost effectiveness of pre-endoscopy coeliac screening with Simtomax in anaemia; 3)
111 strategies such as laparotomy, laparoscopy, endoscopy, computed tomographic angiography, angiographi
112 ate sex-matched control groups: 606 elective endoscopy controls and 303 primary care controls without
115 pothesise that using a point of care test at endoscopy could fill this gap, by providing rapid result
116 partially replace currently used techniques (endoscopy, CT enterography and MR enterography) in the d
120 I pathology review that persists on a second endoscopy, despite intensification of acid-suppressive t
123 to precede AEF development, and postablation endoscopy documenting esophageal ulcer may identify pati
124 ain, and refractory reflux symptoms after an endoscopy does not reveal a mechanical obstruction or an
125 udy design, subjects who presented for upper endoscopy due to various non-emergent causes had gastric
126 review concludes that lower gastrointestinal endoscopy during pregnancy is of low risk for mother and
127 ting the study population to women having an endoscopy during pregnancy or before/after, and only ana
128 wide population-based cohort study, we found endoscopy during pregnancy to be associated with increas
130 endoscopy <1 year before or after pregnancy, endoscopy during pregnancy was associated with preterm b
131 l disease, celiac disease, or liver disease, endoscopy during pregnancy was not linked to preterm bir
133 ause the esophagus is easily accessible with endoscopy, early diagnosis and curative treatment of eso
135 luation with GERD-HRQoL questionnaire, upper endoscopy, esophageal manometry, and 24-hour impedance p
137 se previous upper and lower gastrointestinal endoscopy findings were normal, underwent CT and MR ente
142 ast 1 symptom could avoid risks and costs of endoscopy for more than half the children with celiac di
144 at utilize instruments that require flexible endoscopy for the indications of weight loss or treatmen
145 by the American Society for Gastrointestinal Endoscopy: for diminutive colorectal polyps characterize
147 nd B in intestinal biopsies collected during endoscopy from patients with IBS (n = 183) and without I
151 The European Society for Gastrointestinal Endoscopy guidelines recently recommended prophylactic r
153 d anesthesia care (MAC) for gastrointestinal endoscopy has increased in the Veterans Health Administr
155 ] score and platelet-spleen ratio [PSR]) and endoscopy/hepatic venous pressure gradient measurement.
156 lines for diagnostic evaluation recommending endoscopy (high risk), MR cholangiopancreatography (inte
157 ), 181 (10%) were not confirmed with initial endoscopy (ie, discordant), of which 37 were excluded (a
166 feasible, whereas performance of esophageal endoscopy in the presence of AEF may result in significa
168 = 169) collected from patients who underwent endoscopy in the United Kingdom or the Netherlands and a
169 copies to achieve eradication or to the last endoscopy in those not achieving eradication was compara
170 diagnosed more than 1 year after the initial endoscopy in which BE was diagnosed, respectively).
172 nd panoramic views obtained by full-spectrum endoscopy increased the number of dysplastic lesions det
173 The prediction of pCR through CT-PET and endoscopy independently or combined is limited by low se
174 onths); patients were examined by a median 4 endoscopies (interquartile range, 3-6 endoscopies).
180 atients with advanced liver disease in which endoscopy is mandatory as well as rule out the presence
185 was to assess whether lower gastrointestinal endoscopies (LGEs) across all three trimesters of pregna
190 , cough, aspiration, laryngitis, GERD, GORD, endoscopy, manometry, pH monitoring, proton pump inhibit
191 , cough, aspiration, laryngitis, GERD, GORD, endoscopy, manometry, pH monitoring, proton pump inhibit
192 R before surgery, with metabolic imaging and endoscopy, may spare patients' operative intervention.
193 oscopic cholecystectomy (n = 10 studies) and endoscopy (n = 10 studies), participants who reached sim
194 ither underwent RFA (n = 45) or surveillance endoscopy (n = 125) for LGD, confirmed by at least 1 exp
195 rence standard; the results of video-capsule endoscopy (n = 36) and clinical follow-up (n = 59) were
201 n pump inhibitor therapy and/or surveillance endoscopy) of this before undergoing the procedure.
202 questionnaires prior to elective, outpatient endoscopy; of these individuals, 564 were identified as
203 and objective evaluation of inflammation by endoscopy, offers a clinically meaningful and scientific
206 mong physicians, where the majority performs endoscopy on two or more days per week, most prefer prev
210 32% of round 1 participants crossed over to endoscopy over 4 screening rounds-7.0% due to a positive
211 geal dilation (P = 0.04), suspicion of BE at endoscopy (P < 0.001), and histological esophagitis (P =
212 using a visual analogue scale, compared with endoscopy (p < 0.001), and patients who were not sedated
215 FS, 30.3-43.5), upper gastrointestinal tract endoscopy (PFS, 26.5-34.3), mastectomy (PFS, 16.5-35.0),
217 during colonoscopy using a NIR fluorescence endoscopy platform, providing the endoscopist a wide-fie
229 three additional unpublished cases in which endoscopy revealed only minimal changes while laparoscop
230 mucosal inflammation as assessed by the Mayo endoscopy score (P = 0.01), disease activity as indicate
232 atients achieving endoscopic remission (Mayo endoscopy score of 0) had significantly higher IBDQ scor
239 this hypothesis: 1) the availability of pre-endoscopy serology in anaemia; 2) the sensitivities and
241 tool to screen individuals in the office or endoscopy setting; Figure 2 illustrates a strategy for u
242 high-definition/high-resolution white-light endoscopy should be performed under maximal acid suppres
246 on with acute abdomen he had upper and lower endoscopy showing areas of nonspecific patchy erythema.
247 r adverse outcomes of pregnancy according to endoscopy status using 1,589,173 unexposed pregnancies a
249 e new Expanded-Baveno VI criteria spare more endoscopies than the original criteria with a minimal ri
250 ), however when stratified by previous lower endoscopy, the association was only observed in the part
252 ed at baseline and confirmed by a subsequent endoscopy, the odds for progression to neoplasia also in
254 nce every 6 months for 1 year after the last endoscopy, then annually for 2 years, then every 3 years
260 quently diagnosed with IBD (after diagnostic endoscopy) to those of 20 comparison patients with funct
261 can impact probe-based applications such as, endoscopy, tomography, and industrial imaging and sensin
264 lyps >20 mm from 2003 to 2014 in an academic endoscopy unit were retrospectively analyzed for size, l
265 ow-band imaging is an image-enhanced form of endoscopy used to observed microstructures and capillari
268 rointestinal pathology review), repeat upper endoscopy using high-definition/high-resolution white-li
272 of UGIB among the 86 patients who underwent endoscopy was oesophageal varices (57%), followed by pep
281 , for which only 1 birth had been exposed to endoscopy, we found no association between endoscopy and
284 irs, overall sensitivity and specificity for endoscopy were 74% and 85%, positive predictive value wa
287 , raised serum total bilirubin and a lack of endoscopy were independent predictors of mortality.
288 .001), and patients who were not sedated for endoscopy were more likely to rate the Cytosponge higher
290 tom-line belief in the value of surveillance endoscopy when evaluating a patient's likelihood of comp
291 ed with patients without GERD by GerdQ or by endoscopy with 24-h pH monitoring (PHM) and in normal vo
292 r disease (cACLD) can safely avoid screening endoscopy with a platelet count >150 x 10(9) cells/L and
293 t study of patients scheduled for outpatient endoscopy with anesthesia at a county hospital serving t
296 l polyps was evaluated using high-definition endoscopy with digital chromoendoscopy and the accuracy
297 days and underwent an upper gastrointestinal endoscopy with duodenal biopsy of the distal duodenum at
299 All eligible patients were proposed an upper endoscopy with multistaged esophageal biopsies under gen
300 te may be achieved by molecular fluorescence endoscopy with targeted near-infrared (NIR) fluorescent
301 hibitor; and 4) patients receiving follow-up endoscopy within the 3(rd) and the 4(th) months after tr
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。